Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The next generation of the first and most proven sacral neuromodulation system.
Download the brochurePowerful
Personalized
Proven
90+
clinical
trials
350,000+
patients
treated
25
years SNM
experience
70+
FDA
approvals
The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.
Model |
97800 |
---|---|
Battery type |
Recharge-free |
Weight |
22 g |
Height |
44 mm |
Length |
51 mm |
System components |
|
Under expected therapy settings and telemetry use.
Please see system eligibility, battery longevity, specifications manual for battery longevity estimates.
Compared to patient fob.
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018, 229 -236.
Medtronic InterStim Therapy Clinical Summary (2018).
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):23.